Provided by Tiger Trade Technology Pte. Ltd.

West Pharmaceutical

254.34
+5.322.14%
Post-market: 254.340.00000.00%18:22 EST
Volume:814.39K
Turnover:206.03M
Market Cap:18.30B
PE:37.46
High:254.40
Open:247.87
Low:246.78
Close:249.02
52wk High:322.34
52wk Low:187.43
Shares:71.94M
Float Shares:71.41M
Volume Ratio:1.09
T/O Rate:1.14%
Dividend:0.85
Dividend Rate:0.33%
EPS(TTM):6.79
EPS(LYR):6.79
ROE:16.85%
ROA:10.09%
PB:5.76
PE(LYR):37.46

Loading ...

West Pharmaceutical Services Signals HVP‑Led Growth Ahead

TIPRANKS
·
Feb 13

BUZZ-U.S. STOCKS ON THE MOVE-FedEx Corp, Lincoln National

Reuters
·
Feb 13

Stock Track | West Pharmaceutical Plummets 7.52% Intraday Despite Earnings Beat as Growth Concerns Surface

Stock Track
·
Feb 13

West Pharmaceutical Services Shares up 2.8% After Upbeat 2026 Profit Forecast

THOMSON REUTERS
·
Feb 12

West Pharmaceutical: Strong Quarterly Beat and Confident 2026 Outlook Support Buy Rating Despite GLP‑1 Concerns

TIPRANKS
·
Feb 12

BUZZ-U.S. STOCKS ON THE MOVE-PPG Industries, American Electric Power, West Pharmaceutical

Reuters
·
Feb 12

West Pharmaceutical Shares up 4.5% Premarket After Co Forecasts 2026 Profit Above Estimates

THOMSON REUTERS
·
Feb 12

West Pharma Exec Says It Continues to Expect Growth From Both Injectable and Oral Forms of Glp-1 in 2026 - Conf Call

THOMSON REUTERS
·
Feb 12

West Pharma Exec Says Glp‑1 Demand Expected to Grow in 2026, Though at a Slower Pace Than 2025 - Conf Call

THOMSON REUTERS
·
Feb 12

West Pharma Exec Says Co Sees No Change in Customer Behavior and Describes Its Annual Forecast as a Conservative Start- Conf Call

THOMSON REUTERS
·
Feb 12

West Pharma Exec Says Co Expects 2026 Will Have "Broad Based Growth Profile" Driven by Non Glp-1 Hvp Components Growing High Single Digits to Low Single Digits - Conf Call

THOMSON REUTERS
·
Feb 12

West Pharma Exec Says Glp‑1 Adoption Would Need to Exceed 30% to Reach 10% Year-Over-Year Growth for Co - Conf Call

THOMSON REUTERS
·
Feb 12

BUZZ-West Pharmaceuticals rises after upbeat 2026 profit forecast

Reuters
·
Feb 12

West Pharma forecasts 2026 profit above estimates on strong demand for drug components

Reuters
·
Feb 12

West Pharmaceutical sees Q1 adjusted EPS $1.65-$1.70, consensus $1.65

TIPRANKS
·
Feb 12

West Pharmaceutical reports Q4 adjusted EPS $2.04, consensus $1.83

TIPRANKS
·
Feb 12

GUIDANCE: (WST) West Pharmaceutical Expects 2026 Adjusted EPS Range $7.85 to $8.20, vs. FactSet Est of $7.80

MT Newswires Live
·
Feb 12

Stock Track | West Pharmaceutical Soars 5.90% in Pre-Market on Strong Q4 Earnings Beat and Positive Guidance

Stock Track
·
Feb 12

BRIEF-West Pharmaceutical Q4 Adjusted EPS USD 2.04 Vs. IBES Estimate USD 1.83

Reuters
·
Feb 12

West Reports Fourth-Quarter and Full-Year 2025 Results

THOMSON REUTERS
·
Feb 12